BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8472397)

  • 1. Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins.
    Shi YE; Torri J; Yieh L; Sobel ME; Yamada Y; Lippman ME; Dickson RB; Thompson EW
    Clin Exp Metastasis; 1993 May; 11(3):251-61. PubMed ID: 8472397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells.
    van den Brûle FA; Engel J; Stetler-Stevenson WG; Liu FT; Sobel ME; Castronovo V
    Int J Cancer; 1992 Oct; 52(4):653-7. PubMed ID: 1399148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
    Castronovo V; Taraboletti G; Liotta LA; Sobel ME
    J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of 32/67-kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines.
    Kim WH; Lee BL; Jun SH; Song SY; Kleinman HK
    Br J Cancer; 1998; 77(1):15-20. PubMed ID: 9459140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines.
    Savoldi G; Ferrari F; Ruggeri G; Sobek L; Albertini A; Di Lorenzo D
    Int J Biol Markers; 1995; 10(1):47-54. PubMed ID: 7629427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of membrane-associated 67-kDa laminin receptor (67LR) is modulated in vitro by cell-contact inhibition.
    Donaldson EA; McKenna DJ; McMullen CB; Scott WN; Stitt AW; Nelson J
    Mol Cell Biol Res Commun; 2000 Jan; 3(1):53-9. PubMed ID: 10683318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
    Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
    Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.
    Berno V; Porrini D; Castiglioni F; Campiglio M; Casalini P; Pupa SM; Balsari A; Ménard S; Tagliabue E
    Endocr Relat Cancer; 2005 Jun; 12(2):393-406. PubMed ID: 15947111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.
    Pesapane A; Ragno P; Selleri C; Montuori N
    Curr Pharm Des; 2017; 23(32):4745-4757. PubMed ID: 28699539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.
    Gill PG; Tilley WD; De Young NJ; Lensink IL; Dixon PD; Horsfall DJ
    Breast Cancer Res Treat; 1991 Dec; 20(1):53-62. PubMed ID: 1813069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB
    Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells.
    Montuori N; Müller F; De Riu S; Fenzi G; Sobel ME; Rossi G; Vitale M
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2086-92. PubMed ID: 10372715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis is required for laminin-induced expression of the 67-kDa laminin receptor and its 37-kDa precursor.
    Romanov VI; Wrathall LS; Simmons TD; Pinto da Silva P; Sobel ME
    Biochem Biophys Res Commun; 1995 Mar; 208(2):637-43. PubMed ID: 7695618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
    Viacava P; Naccarato AG; Collecchi P; Ménard S; Castronovo V; Bevilacqua G
    J Pathol; 1997 May; 182(1):36-44. PubMed ID: 9227340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization.
    Selleri C; Ragno P; Ricci P; Visconte V; Scarpato N; Carriero MV; Rotoli B; Rossi G; Montuori N
    Blood; 2006 Oct; 108(7):2476-84. PubMed ID: 16788104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell localization and redistribution of the 67 kD laminin receptor and alpha 6 beta 1 integrin subunits in response to laminin stimulation: an immunogold electron microscopy study.
    Romanov V; Sobel ME; pinto da Silva P; Menard S; Castronovo V
    Cell Adhes Commun; 1994 Jul; 2(3):201-9. PubMed ID: 7827956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin receptor in lymph node negative breast carcinoma.
    Nadji M; Nassiri M; Fresno M; Terzian E; Morales AR
    Cancer; 1999 Jan; 85(2):432-6. PubMed ID: 10023712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D.
    Moore MR; Hathaway LD; Bircher JA
    Biochim Biophys Acta; 1991 Feb; 1096(2):170-4. PubMed ID: 2001431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.